REVIEWS |
|
L.Yu. Khamnueva, K.A. Sergeeva, L.S. Andreeva, A.V. Davydova
Endocrinopathies induced by immune check point inhibitors. Optimal patient management tactics
|
8-13 |
|
L.V. Kvitkova, A.S. Khalimova, O.S. Kravchenko
Modern concepts of the mechanisms of oncogenesis in the thyroid gland. The role of dyselementosis, insulin resistance, growth factors: facts and hypotheses
|
14-19 |
|
E.V. Svechnikova (1, 2), S.G. Lykova (2), O.B. Nemchaninova (2), M.A. Morzhanaeva (2)
Clinical features of skin lesions in patients with diabetes mellitus
|
20-25 |
|
|
N.A. Demidov (1), O.M. Koteshkova (2), M.B. Antsiferov (2)
Modern approaches to using the FreeStyle Libre Flash glucose monitoring system
|
26-32 |
|
T.B. Morgunova, V.V. Fadeyev
Combination of two hypoglycemic drugs for type 2 diabetes mellitus
|
33-37 |
ORIGINAL ARTICLES |
|
A.M. Mkrtumyan (1, 2), S.V. Vorobyev (3), A.R. Volkova (4), N.V. Vorokhobina (5)
Effect of Subetta on glycemic control in patients with type 2 diabetes mellitus: results of a multicenter, double-blind, placebo-controlled, randomized clinical study
|
38-48 |
|
A.F. Verbovoy, T.V. Lomonova
Resistin levels and metabolic parameters in patients type 2 diabetes mellitus in combination with hypothyroidism
|
49-54 |
|
L.I. Velikanova, Z.R. Shafigullina, N.V. Vorokhobina, E.V. Malevanaya, Zh.V. Paltsman, A.V. Kuznetsova
Adrenal incidentalomas: diagnostics of hormonal disorders by gas chromatography-mass spectrometry
|
56-62 |
|
E.V. Pronin (1), M.B. Antsiferov (1), T.M. Alekseeva (1), V.S. Pronin (2)
Experience of using pegvisomantin the combined treatment of acromegaly
|
64-72 |
|
N.A. Shkurova, N.I. Baranova, A.V. Fedin
Improvement of the efficacy of conservative treatment of rhinosinusitis and otitis media in patients with type 2 diabetes mellitus: an open-label prospective randomized clinical trial
|
73-76 |
|
T.P. Demicheva
Possibilities of using taurine in the treatment of psychovegetative disorders in patients with type 2 diabetes mellitus
|
77-79 |
|
E.V. Shchukina (1), V.D. Gromenkov (2), Y.V. Suprun (2), I.S. Mykhailichenko (1), E.V. Beryozova (2), V.A. Bagriy (3), I.A. Golodnikov (1)
Vasodilating beta-adrenoceptor blockers in post-myocardial infarction patients with type 2 diabetes
|
80-85 |
|
L.I. Shevchenko, Kh. Ya. Karimov, T.R. Alimov, O. V. Lubentsova, M.N. Ibragimov
The effect of a new amino acid agent on protein metabolism, the intensity of lipid peroxidation and the state of the antioxidant system in experimental protein-energy deficiency
|
86-90 |
Resolution |
|
M.B. Antsiferov (1), G.R. Galstyan (2)
Resolution on the results of the expert panel “IDegLira: is it 1+1 or anything more?”
|
91-98 |
|
|
E.V. Pronin (1), V.S. Pronin (2)
Contribution of somatostatin analogues to the implementation of a patient-oriented approach to the treatment of acromegaly
|
99-106 |
|
L.Yu. Khamnueva (1), L.S. Andreeva (1), A.V. Davydova (1), E.V. Chugunova (1), N.P. Tokareva (2), N.Yu. Molodtsova (1)
The use of fixed ratio combination of insulin glargine and lixisenatide in patients with type 2 diabetes mellitus in real clinical practice. Own clinical experience
|
107-111 |
|
V.F. Rusakov (1), D.V. Rebrova (1), N.I. Timofeeva (1), A.A. Belousova (1), T.V. Savelyeva (1), R.A. Chernikov (1), I.V. Sleptsov (1), T.S. Pridvizhkina (1), N.V. Vorokhobina (2), Yu.N. Fedotov (1)
Acromegaly and diffuse multinodular goiter: clinical cases
|
112-119 |
Русский
